| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | f6113982-e3b7-4f42-ae6f-65374f00c7fa | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 11b2f885-b837-455c-8d77-0b38e14e35c3 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 2004 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 3bc870c2-e1db-44ca-9552-ea5981fd3c33 | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2912a0e7-6bcf-4b08-b67e-6a271e8ae311 | 11 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | cbd3b7dc-da04-4497-be3c-b94363d6876f | 20 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 8dd7ab8f-2cb0-4600-9f57-ab5cef171559 | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 0d52ee7d-a955-4263-b53b-b697c3fa013d | 8 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 9665e134-2343-493d-9bbe-7b3dc577eb01 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Emergency Zit Stick Treatment | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 6fdff658-fd36-44a2-8955-a80536960131 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 02d41467-ffed-40f6-ac2a-4c4266557e3d | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | afad39b6-b0a1-48a9-b26b-0602bfc121be | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 98b0ca9a-719f-4e1e-ade6-c80a4455a5b3 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 0222f7ec-86ae-474d-ae9a-8ca1b98938a3 | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Active Ingredients | 7 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | cdc7af8a-2c09-43e5-b873-cf3eb576c212 | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use Cleviprex safely and effectively. See full prescribing information for Cleviprex. Cleviprex (clevidipine) injectable emulsion, for intravenous use Initial U.S. Approval: 2008 | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Aspirin EC 81 mg | 17 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use AZITHROMYCIN safely and effectively. See full prescribing information for AZITHROMYCIN. AZITHROMYCIN for IV infusion only Initial U.S. Approval: 1991 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 253fdee7-5060-4b49-ad26-257eb54cccfa | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Pleasure Balm | 10 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use FORTICAL ® safely and effectively. See full prescribing information for FORTICAL. FORTICAL ® (calcitonin-salmon [rDNA origin]) Nasal Spray for intranasal use Initial U.S. Approval: 2005 | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2026988d-7dfa-49ac-bd64-4c2bba197c39 | 7 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | cb93958f-5c64-4aae-89f1-d5b5048baf6f | 8 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ea4d9094-1aca-4c0f-a67d-7276a9fd591b | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ca1ef1af-714b-4b0b-b816-c6ce12b4c865 | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 41717ae2-b729-4970-b32a-8c2ada32e5b9 | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | f0e3d80e-7cd9-4391-bc65-5d210cc704d8 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 985d0bdb-2a45-43a7-9267-6504d76de39c | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Neova DNA Damage Control - Silc Sheer SPF 40 - Drug Facts | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | b49dcf3f-14d1-4a8b-94c7-e7f4de5d282e | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use epirubicin hydrochloride injection safely and effectively. See full prescribing information for epirubicin hydrochloride injection. EPIRUBICIN Hydrochloride Injection for intravenous use Initial U.S. Approval: 1999 | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 83de9eef-aca5-449d-8365-a30c78652a2e | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Amerisource Bergen Eye Itch Relief Drug Facts | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Diabecline | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Oral Defense Fluoride Rinse | 12 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 3 Step First Aid Kit Medication Filled Swabs | 11 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 5678be04-5e19-4c87-8eca-5222b849660e | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Methergine | 1000 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Aspirin NSAIDS EC Tablet 325mg- 5gr | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | eb2b27ce-332a-48c1-9ae4-e2b5c2b11bb1 | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 3d15d591-76d5-454c-b491-3d2406710c4b | 8 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 7c7431eb-93e0-4d79-a995-27edbdacfb46 | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Oral Defense Mouth Rinse | 17 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | silver sulfadiazine 1% cream | 3792 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | 3706 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Amino Mask | 8 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Drug Facts | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | d02aec6b-b973-4e88-b42e-adb1ea7a6078 | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 37b694d8-8c23-4a4b-8919-70229bf3526e | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | a51fc004-9538-4e67-8f49-002babe17f9e | 9 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | INFUVITE ® ADULT Multiple Vitamins for Infusion | 10 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Oral Solution USP Initial U.S. Approval: 1993 | 9 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | These highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 1959 | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Drug Facts | 9 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | Drug Facts | 8 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | Drug Facts | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | Leuprolide Acetate Injection | 13 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DRUG FACTS | 18 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DRUG FACTS | 13 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DRUG FACTS | 13 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DRUG FACTS | 7 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | Drug Facts | 7 | |
| SODIUM HYDROXIDE | ACTIVE INGREDIENT | 55X04QC32I | SODIUM HYDROXIDE | 11 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | Fluorouracil Injection, USP | 11 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPY DBA QUALITY CARE PRODUCTS LLC] | 3884 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LACTULOSE SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3880 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LIDOCAINE HYDROCHLORIDE SOLUTION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3874 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3864 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | POLYMYXIN B SULFATE AND TRIMETHOPRIM (POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3852 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PATADAY (OLOPATADINE HYDROCHLORIDE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3728 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3642 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ERYTHROMYCIN BASE FILMTAB (ERYTHROMYCIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3641 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC] | 3607 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3585 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC] | 3575 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | OXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3474 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3473 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | OXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3445 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TRANZGEL (ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, ACONITUM NAPELLUS, ARNICA MONTANA, CALENDULA OFFICIANALIS, HAMAMELIS VIRGINIANA, BELLADONNA, BELLIS PERENNIS, CHAMOMILLIA, MILLEFOLIUM, HYPERICUM PERFORATUM, SYMPHYTUM OFFICINALE, COLCHICINUM) GEL [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3162 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | OXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2101 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | HUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.] | 1805 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DEPACON (VALPROATE SODIUM) INJECTION [ABBVIE INC.] | 1531 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CALCIJEX (CALCITRIOL) INJECTION, SOLUTION [ABBVIE INC.] | 1415 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK] | 1001 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PHENYLEPHRINE HYDROCHLORIDE SOLUTION [BRYANT RANCH PREPACK] | 1001 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEUPOGEN (FILGRASTIM) INJECTION, SOLUTION [AMGEN INC] | 144 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEULASTA (PEGFILGRASTIM) KIT NEULASTA (PEGFILGRASTIM) INJECTION [AMGEN INC] | 126 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ANDROGEL (TESTOSTERONE) GEL [ABBVIE INC.] | 79 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ANDROGEL (TESTOSTERONE) GEL [ABBVIE INC.] | 78 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 56 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION HUMALOG KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 49 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP] | 41 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 34 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | OPTIRAY 350 (IOVERSOL) INJECTION OPTIRAY 320 (IOVERSOL) INJECTION OPTIRAY 300 (IOVERSOL) INJECTION OPTIRAY 240 (IOVERSOL) INJECTION [MALLINCKRODT INC.] | 33 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | HUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY] | 32 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | HUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY
] | 31 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 31 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 31 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | OPTIMARK (GADOVERSETAMIDE) INJECTION, SOLUTION [MALLINCKRODT INC.] | 30 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP] | 29 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TYGACIL (TIGECYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 29 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROTATEQ (ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT) SOLUTION [MERCK SHARP & DOHME CORP.] | 27 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | AVELOX (MOXIFLOXACIN HYDROCHLORIDE) INJECTION, SOLUTION AVELOX (MOXIFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [SCHERING PLOUGH CORPORATION] | 26 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CUBICIN (DAPTOMYCIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 26 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION CLEOCIN PHOSPHATE (0009-6582) (STANDALONE) (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 25 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | HUMATROPE (SOMATROPIN) KIT [ELI LILLY AND COMPANY] | 24 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ACIPHEX (RABEPRAZOLE SODIUM) TABLET, DELAYED RELEASE [EISAI INC.] | 23 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | INVANZ (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 23 | |
